Ana
Martín García
Hospital Universitario Virgen Macarena
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (11)
2023
-
Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity
Clinical and Translational Oncology, Vol. 25, Núm. 11, pp. 3073-3085
2021
-
Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC
Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 438-448
2020
-
Effectiveness of sacubitril–valsartan in cancer patients with heart failure
ESC Heart Failure, Vol. 7, Núm. 2, pp. 763-767
-
Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO
Medicina Clinica, Vol. 155, Núm. 12, pp. 521-528
2019
-
Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations
Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 749-759
-
Replied to “Some remarks to SEOM clinical guidelines on cardiovascular toxicity (2018)”
Clinical and Translational Oncology
-
SEOM clinical guidelines on cardiovascular toxicity (2018)
Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 94-105
2018
-
Short- and Long-Term Prognostic Relevance of Cardiogenic Shock in Takotsubo Syndrome: Results From the RETAKO Registry
JACC: Heart Failure, Vol. 6, Núm. 11, pp. 928-936
-
Tako-tsubo Syndrome in Men: Rare, but With Poor Prognosis
Revista Espanola de Cardiologia, Vol. 71, Núm. 9, pp. 703-708
2017
-
Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations
Revista Espanola de Cardiologia, Vol. 70, Núm. 6, pp. 474-486